Assessing the Impact of Outreach Strategies and Testing Procedures on Participation in Genetic Testing Among High-Risk Groups
-
By
-
Lindsay Dickey
-
Emily Bryce
-
J. B. Rinaldi
-
Kate Emery
-
Kimberly Childers
-
Sandra Brown
-
Ora Gordon
-
Keri Vartanian
-
April 2, 2026
-
Clinical Scorecard: Assessing the Impact of Outreach Strategies and Testing Procedures on Participation in Genetic Testing Among High-Risk Groups
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | High-risk patients with a personal or family history of breast or ovarian cancer. |
| Care Setting | |
Key Highlights
- Address disparities in genetic testing participation by race, age, and insurance coverage.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
- Address disparities in genetic testing by race, age, and insurance coverage.
Patient & Prescribing Data
Genetic testing can inform tailored cancer therapies for patients with hereditable mutations and guide preventive measures.
Clinical Best Practices
- Integrate cancer risk assessments during routine mammograms.
- Leverage technology for electronic risk assessments at scale.
- Focus on same-day testing to enhance patient participation.
- Establish follow-up care protocols post-genetic testing.
References
